The question you need to ask is why did the company pay $835k for the patents, not move forward in any way at all with the drug, and then all of sudden for no reason the patents are worth $1B?? Did you call Camille and ask him what accounted for the increase in valuation from less than $1m to $1b? The phone number is there. I called, asked, and got no answer to this question, but instead got an extremely entertaining conversation.
And no I'm sorry, but a company saying "We intend to sell generics in the future after we apply for the license" does not add any value to the company.
Nobody has yet explained why this company has any value. Just a history of BS. Show me some proof that this drug has real value. That one paragraph that anybody has found about this drug is not proof. Most of the articles are BS from unsafe sites.
News 
Market Data 
Discover 
